Powered by

Diagnostics

The latest articles, press releases and dossiers on diagnostics in Baden-Württemberg

  • Article - 31-Dec-2012

    Can myocardial infarction be diagnosed with a single drop of blood? The answer is yes: a new application of the ESEQuant Lateral Flow System developed by QIAGEN now makes this possible. The system, which is able to identify a broad range of bacterial and viral pathogens, including HIV, influenza virus and Chlamydia, was originally developed at the company’s site in Stockach. It has recently been adapted for use in the diagnosis of myocardial infarction by the Chinese company Lepu Medical Technology and has achieved initial regulatory approval in human healthcare in China.

  • Article - 17-Dec-2012

    Rare diseases are conditions that are too often neglected by research, industry and medicine. Here we use Wilson’s disease as an example to illustrate the particular problems associated with research into and treatment of rare diseases and to provide information on measures that can be taken to improve the situation of people with rare diseases. These measures include central treatment and care institutions and programmes like the Wilson’s disease programme in Heidelberg, which work closely with patient organisations.

  • Press release - 26-Nov-2012

    An estimated 220 million people become infected with malaria each year the disease is often lethal. The infected suffer from a high fever. As this is also the case with other germs however it is important to conduct a rapid and precise analysis to determine the cause of the disease for a successful therapy. A team of researchers aims to develop a rapid test of this kind within the context of the project DiscoGnosis. The project is being coordinated by the Department of Microsystems Engineering IMTEK of the University of Freiburg.

  • Article - 19-Nov-2012

    The prostate genome project, which is part of the International Cancer Genome Consortium, is focused on the genetic and epigenetic causes of the development and progression of this highly variable cancer and finding markers that enable the reliable diagnosis of the disease. The German research groups involved in the project are coordinated by the German Cancer Research Center and concentrate on prostate cancer patients under 50 years of age, as these cases might be key to understanding the development of the disease.

  • Press release - 16-Nov-2012

    Prof. Dr. Michael Reth has been awarded an Advanced Grant of the European Research Council ERC. The 2.24 million Euro award will be used to fund research over the next 5 years. The Albert-Ludwigs-University scientist wants to use this special funding to explore the nanoscale organization of proteins in biological membranes. With his nanoscale explorer program Reth and his group wish to obtain new insights into membrane processes of normal and diseased cells.

  • Article - 29-Oct-2012

    Researchers are usually only able to explore the development and growth of tumours with animal models. This is because many human cells lose their typical characteristics once outside the body. Friederike J. Gruhl from the Karlsruhe Institute of Technology KIT is working to create a biomimetic environment in Petri dishes in which prostate cells thrive and can be manipulated to become tumours for example - if required. The three-dimensional prostate model will provide insights into the complexity of the prostate. Gruhl has expanded the horizons of biology during the course of her investigations.

  • Article - 29-Oct-2012

    Tilman Schäffer at the University of Tübingen creates a bridge between physics, biology and medicine. His speciality is innovative microscopic detection methods such as atomic force microscopy. In addition to application, Schäffer is working on improving scanning probe microscopy instrumentation and methods.

  • Press release - 26-Oct-2012

    Europe-wide network for investigating irritable bowel syndrome headed by Heidelberg University HospitalEuropean Science Foundation provides 500000 euros in funding for understanding causes improving options for diagnosis and treatment.

  • Article - 22-Oct-2012

    Functional medical imaging modalities are of great significance in modern medical diagnostics. Existing ways of diagnosing diseases are now being expanded with the arrival of the innovative parameter imaging method. syneed imaging uses proprietary highly sensitive software for the analysis of dynamic image data. This software complements standard methods such as computed tomography and magnetic resonance imaging and increases the significance of image data in clinical trials and therapy decisions.

  • Article - 15-Oct-2012

    Detecting viruses, bacteria or parasites in human, animal, food and environmental samples is routine for the staff of gerbion GmbH & Co. KG. The company has been using virological, microbiological and serological methods for many years, but is now also using cutting-edge molecular biology methods for detecting pathogens. The founders of the Kornwestheim-based diagnostics company have concentrated on own research work and the development of new detection methods and tests right from the word go.

  • Article - 08-Oct-2012

    On the occasion of its 50th anniversary, the Institute of Human Genetics at the University Hospital of Heidelberg celebrates its major achievements in molecular genetic analyses, the diagnosis of hereditary diseases and tumour diseases as well as its research into the molecular causes of genetic defects. The largest institute of human genetics in Germany is also at the forefront of genetic counselling and debates on health policies and ethical issues.

Website address: https://www.gesundheitsindustrie-bw.de/en/article/diagnostics/?block_75783size=12&block_75783from=108